These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 27590272

  • 1. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
    Qian CY, Zheng Y, Wang Y, Chen J, Liu JY, Zhou HH, Yin JY, Liu ZQ.
    Chin J Cancer; 2016 Sep 02; 35(1):85. PubMed ID: 27590272
    [Abstract] [Full Text] [Related]

  • 2. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
    Tan X, Wu Q, Cai Y, Zhao X, Wang S, Gao Z, Yang Y, Li X, Qian J, Wang J, Su B, Chen H, Han B, Jiang G, Lu D.
    Clin Lung Cancer; 2014 Jan 02; 15(1):67-78.e12. PubMed ID: 24220096
    [Abstract] [Full Text] [Related]

  • 3. ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
    De Troia B, Dalu D, Filipazzi V, Isabella L, Tosca N, Ferrario S, Gambaro AR, Somma L, Fasola C, Cheli S, Clementi E, De Francesco D, Falvella FS, Cattaneo MT.
    Cancer Chemother Pharmacol; 2019 Apr 02; 83(4):803-808. PubMed ID: 30796464
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D receptor genetic variants are associated with chemotherapy response and prognosis in patients with advanced non-small-cell lung cancer.
    Xiong L, Cheng J, Gao J, Wang J, Liu X, Wang L.
    Clin Lung Cancer; 2013 Jul 02; 14(4):433-9. PubMed ID: 23522953
    [Abstract] [Full Text] [Related]

  • 5. Genetic variations in ABC transporter genes as a predictive biomarker for toxicity in North Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P, Singh N, Sharma S.
    J Biochem Mol Toxicol; 2023 Mar 02; 37(3):e23269. PubMed ID: 36507589
    [Abstract] [Full Text] [Related]

  • 6. Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.
    Kim SH, Kim MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY, Ling H, Lee GW.
    Am J Clin Oncol; 2015 Jun 02; 38(3):294-9. PubMed ID: 23689644
    [Abstract] [Full Text] [Related]

  • 7. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
    Xu JL, Wang ZW, Hu LM, Yin ZQ, Huang MD, Hu ZB, Shen HB, Shu YQ.
    Asian Pac J Cancer Prev; 2012 Jun 02; 13(5):2157-62. PubMed ID: 22901187
    [Abstract] [Full Text] [Related]

  • 8. Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients.
    Peng Y, Li Z, Zhang S, Xiong Y, Cun Y, Qian C, Li M, Ren T, Xia L, Cheng Y, Wang D.
    Int J Cancer; 2014 Dec 01; 135(11):2687-96. PubMed ID: 24729390
    [Abstract] [Full Text] [Related]

  • 9. Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P, Singh N, Sharma S.
    J Gene Med; 2023 Jan 01; 25(1):e3460. PubMed ID: 36314103
    [Abstract] [Full Text] [Related]

  • 10. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
    Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA.
    Gynecol Oncol; 2012 Mar 01; 124(3):575-81. PubMed ID: 22112610
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients.
    Deng JH, Deng J, Shi DH, Ouyang XN, Niu PG.
    Clin Transl Oncol; 2015 Sep 01; 17(9):720-6. PubMed ID: 26033426
    [Abstract] [Full Text] [Related]

  • 12. Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.
    Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, Xu J, Lv M, Zhang J, Zhou C.
    Lung Cancer; 2012 Jan 01; 75(1):102-9. PubMed ID: 21676483
    [Abstract] [Full Text] [Related]

  • 13. Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy.
    Li X, Shao M, Wang S, Zhao X, Chen H, Qian J, Song X, Wang J, Jin L, Wu J, Li Q, Bai C, Han B, Gao Z, Lu D.
    Tumour Biol; 2014 Nov 01; 35(11):11159-70. PubMed ID: 25104092
    [Abstract] [Full Text] [Related]

  • 14. Effect of GSTP1 and ABCC2 Polymorphisms on Treatment Response in Patients with Advanced Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy: A Study in a Chinese Uygur Population.
    Han ZG, Tao J, Yu TT, Shan L.
    Med Sci Monit; 2017 Apr 26; 23():1999-2006. PubMed ID: 28442702
    [Abstract] [Full Text] [Related]

  • 15. The impact of functional LIG4 polymorphism on platinum-based chemotherapy response and survival in non-small cell lung cancer.
    Jiang YH, Xu XL, Ruan HH, Xu WZ, Li D, Feng JG, Han QB, Mao WM.
    Med Oncol; 2014 May 26; 31(5):959. PubMed ID: 24722796
    [Abstract] [Full Text] [Related]

  • 16. Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non-Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery.
    Santarpia M, Ramirez JL, de Aguirre I, Garrido P, Pérez Cano M, Queralt C, Gonzalez-Larriba JL, Insa A, Provencio M, Isla D, Camps C, Blanco R, Moran T, Rosell R, Spanish Lung Cancer Group.
    Clin Lung Cancer; 2017 Mar 26; 18(2):178-188.e4. PubMed ID: 27908619
    [Abstract] [Full Text] [Related]

  • 17. RB1 polymorphism contributes to the efficacy of platinum-taxanes in advanced squamous cell lung cancer.
    Liu D, Xu W, Zhang ZW, Qian J, Zheng H, Zhang J, Su B.
    Asian Pac J Cancer Prev; 2015 Mar 26; 16(2):775-81. PubMed ID: 25684524
    [Abstract] [Full Text] [Related]

  • 18. Lack of any relationship between chemotherapy toxicity in non-small cell lung cancer cases and polymorphisms in XRCC1 codon 399 or XPD codon 751.
    Li Y, Huang XE, Jin GF, Shen HB, Xu L.
    Asian Pac J Cancer Prev; 2011 Mar 26; 12(3):739-42. PubMed ID: 21627375
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.